Sign in
8-K

Current Report

MoonLake Immunotherapeutics Filed Acc 0001213900-23-047184

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading ea179949-8k_moonlake.htm…